Ex-FTC Official Pans Claim Gilead-Teva Deal Hurt Competition

By Gina Kim · June 23, 2023, 10:35 PM EDT

California federal jurors considering claims that pharmaceutical companies Gilead Sciences Inc. and Teva Pharmaceutical Industries Ltd. reached an illegal agreement to delay generic versions of HIV medications heard from a former...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

In re HIV Antitrust Litigation

Case Number

3:19-cv-02573

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

May 14, 2019